Covington Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-55
Closed -$2K 1224
2022
Q1
$2K Buy
+55
New +$1.51K ﹤0.01% 1052

Covington Capital Management's XENT Position: Q2 2022 in Review

Covington Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 55 shares — an estimated $2K sold.

Covington Capital Management first reported a position in XENT in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Covington Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Covington Capital Management sold 55 Intersect ENT, Inc shares in Q2 2022, an estimated $2K.
  • Covington Capital Management first reported a position in Intersect ENT, Inc in Q1 2022 and held it in 1 quarter.
  • Covington Capital Management's Intersect ENT, Inc position peaked at $2K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Covington Capital Management's 13F filing for Q2 2022, filed 8 Jul 2022.